Atreca Stock Price, News & Analysis
Company Description
Atreca (OTC: BCEL) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector.
BCEL stock has declined 100.0% over the past year. Shares last traded at $0.0900.
This page provides a comprehensive overview of BCEL stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Atreca (BCEL) stock last traded at $0.0900. Over the past 12 months, the stock has lost 100.0%.
Latest News
Atreca has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 7 with negative movement. Key topics include acquisition, earnings, clinical trial, conferences. View all BCEL news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
BCEL Company Profile & Sector Positioning
Atreca (BCEL) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the OTC.